Pixium Vision announces the drawdown of a further tranche, with a nominal value of €1.5 million, under the financing contract with ESGO
19 avr. 2021 14h00 HE | Pixium Vision
Pixium Vision announces the drawdown of a further tranche, with a nominal value of €1.5 million, under the financing contract with ESGO Paris, 19 April 2021 – 8.00 p.m. CET – Pixium Vision...
Pixium-color-2600x800.png
Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021.
18 avr. 2021 13h00 HE | Pixium Vision
Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. Paris, 16 April 2021 – 6:00 p.m. CEST - Pixium Vision...
  Pixium Vision annonce sa position de trésorerie au 31 mars 2021 et fait le point sur ses activités et sa visibilité financière jusqu’à la fin de l’année 2021.
16 avr. 2021 12h30 HE | Pixium Vision
                       Pixium Vision annonce sa position de trésorerie au 31 mars 2021 et fait le point sur ses activités et sa visibilité financière jusqu’à la fin de l’année 2021. Paris, le 16...
Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera
07 avr. 2021 01h00 HE | Pixium Vision
Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera Study is the last clinical step before seeking market approval in Europe in dry AMDBionic vision...
Pixium Vision annonce l’implantation réussie du premier patient de l’étude pivot PRIMAvera du Système Prima
07 avr. 2021 01h00 HE | Pixium Vision
Pixium Vision annonce l’implantation réussie du premier patient de l’étude pivot PRIMAvera du Système Prima Cette étude est la dernière étape clinique avant la demande d’autorisation de mise sur le...
Termination of the business combination with Second Sight Medical Products, Inc.
02 avr. 2021 19h30 HE | Pixium Vision
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private placement recently announced and closed by Second Sight Medical...
Abandon du rapprochement avec Second Sight Medical Products, Inc.
02 avr. 2021 19h30 HE | Pixium Vision
Abandon du rapprochement avec Second Sight Medical Products, Inc. Paris, France, 3 avril 2021 – Compte-tenu de l’augmentation de capital réalisée récemment par Second Sight Medical Products, Inc....
Pixium-color-2600x800.png
Termination of the business combination with Second Sight Medical Products, Inc.
02 avr. 2021 19h30 HE | Pixium Vision
Termination of the business combination with Second Sight Medical Products, Inc. Paris, France, April 3, 2021 – Considering the private placement recently announced and closed by Second Sight Medical...
Pixium Vision annonce de nouveaux résultats probants pour son Système Prima, démontrant qu’il est possible de combiner vision prosthétique et vision naturelle
30 mars 2021 01h00 HE | Pixium Vision
Pixium Vision annonce de nouveaux résultats probants pour son Système Prima, démontrant qu’il est possible de combiner vision prosthétique et vision naturelle Les données marquent une étape majeure...
Pixium-color-2600x800.png
Pixium Vision announces new compelling results with Prima System demonstrating integration of prosthetic and natural vision
30 mars 2021 01h00 HE | Pixium Vision
Data mark a major step forward in treatment of atrophic AMD Results confirm the safety and stability of the Prima System implant over 24-30 months follow-upPrima System pivotal PRIMAvera study ongoing...